Literature DB >> 8120928

Ocular myasthenia gravis.

G A March1, L N Johnson.   

Abstract

Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations. The clinical manifestations, diagnosis, treatment, and prognosis of ocular myasthenia gravis are reviewed.

Entities:  

Mesh:

Year:  1993        PMID: 8120928      PMCID: PMC2568131     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  25 in total

Review 1.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

2.  Plasma exchange in myasthenia gravis: electrophysiological studies.

Authors:  W W Campbell; R T Leshner; T R Swift
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

3.  Asymmetrical pupillary slowing and degree of severity in myasthenia gravis.

Authors:  R C Bryant
Journal:  Ann Neurol       Date:  1980-03       Impact factor: 10.422

4.  The Tensilon test. A safe office procedure.

Authors:  H J Van Dyk; L Florence
Journal:  Ophthalmology       Date:  1980-03       Impact factor: 12.079

5.  The classification and management of acute orbital pseudotumors.

Authors:  J Rootman; R Nugent
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

6.  Myasthenic sustained gaze fatigue.

Authors:  R H Osher; J S Glaser
Journal:  Am J Ophthalmol       Date:  1980-03       Impact factor: 5.258

7.  Pupillary fatigue in myasthenia gravis.

Authors:  G N Dutton; J A Garson; R B Richardson
Journal:  Trans Ophthalmol Soc U K       Date:  1982

8.  Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

9.  Prognosis of ocular myasthenia.

Authors:  C T Bever; A V Aquino; A S Penn; R E Lovelace; L P Rowland
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

10.  Ptosis with contralateral lid retraction due to excessive innervation of the levator palpebrae superiorus.

Authors:  R J Schechter
Journal:  Ann Ophthalmol       Date:  1978-10
View more
  2 in total

1.  "Why do I always see double?" A misdiagnosed case of ocular myasthenia gravis for 10 years.

Authors:  Uduman Ali Mohamed Yousuf; B M Yashodhara; Thevi Thanigasalam; Heng Siang Ting
Journal:  BMJ Case Rep       Date:  2014-05-02

2.  Myasthenia Gravis with Elderly Onset at Advanced Age.

Authors:  Otto Jesus Hernandez Fustes; Carlos Arteaga Rodriguez; Olga Judith Hernandez Fustes
Journal:  Cureus       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.